PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited…
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
May 23, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., May…
Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia
Preclinical research demonstrates that a single administration of BE-102 provides continuous secretion…
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
March 21, 2025 16:30 ET | Source: I-Mab Biopharma ROCKVILLE, Md., March…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates…
Colorado BioScience Association Appoints Four Ecosystem Leaders to Board of Directors
Leaders from BioMed Realty, Fitzsimons Innovation Community, J.P. Morgan, and Umoja Biopharma…
Can-Fite Innovative Publication: Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
March 03, 2025 06:00 ET | Source: Can-Fite BioPharma Ltd. Unlike chemotherapy…
Biologics Conference 2025 Concludes Successfully, Setting New Benchmarks in Biopharmaceutical Innovation and Collaboration
MUMBAI, India, Feb. 14, 2025 /PRNewswire/ -- The Institute of Chemical Technology, Mumbai,…
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
February 07, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., Feb.…